Stay updated with breaking news from Senza Omnia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com cut shares of Nevro (NYSE:NVRO – Free Report) from a hold rating to a sell rating in a research note released on Wednesday morning. Several other analysts have also issued reports on the company. Truist Financial upped their target price on Nevro from $22.00 to $23.00 and gave the stock a hold rating in […]
Canaccord Genuity Group reissued their hold rating on shares of Nevro (NYSE:NVRO – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has a $23.00 price target on the medical equipment provider’s stock. A number of other brokerages have also recently weighed in on NVRO. Truist Financial reduced […]
Canaccord Genuity Group downgraded shares of Nevro (NYSE:NVRO – Free Report) from a buy rating to a hold rating in a report published on Thursday, Marketbeat Ratings reports. They currently have $23.00 price target on the medical equipment provider’s stock. Several other equities analysts have also recently issued reports on the stock. Morgan Stanley lowered […]
Nevro (NYSE:NVRO – Get Free Report)‘s stock had its “outperform” rating reissued by Royal Bank of Canada in a research report issued to clients and investors on Friday, Benzinga reports. They currently have a $23.00 price target on the medical equipment provider’s stock. Royal Bank of Canada’s price target would suggest a potential upside of […]
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...